Therapeutic angiogenesis for the management of refractory angina: current concepts. - Wikidata - wikimedia - TriplyDB

Therapeutic angiogenesis for the management of refractory angina: current concepts.

Therapeutic angiogenesis for the management of refractory angina: current concepts.

http://www.wikidata.org/entity/Q37734560

about

Microvascular repair: post-angiogenesis vascular dynamics 3D Fusion Framework for Infarction and Angiogenesis Analysis in a Myocardial Infarct Minipig Model Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease Inhibition of acid sensing ion channel by ligustrazine on angina model in rat Antagonist molecules in the treatment of angina Experimental and early investigational drugs for angina pectoris.

P2860

Q27004093-C1BC3856-ABA9-448F-8EDC-2D03952B1984 Q33795447-713B8FF9-A416-4060-96F3-7827F7FF7323 Q36087505-3756ABDD-C48B-4277-8A65-5B8E077EE422 Q36309477-F4A5663C-8AE7-40DF-90CE-BC02931DF823 Q38139089-61436ECE-20FE-4118-A2A2-87F3C69DCDDC Q38803136-3D75063F-0530-4259-B5E8-E771083F98AA

P2860

Therapeutic angiogenesis for the management of refractory angina: current concepts.

http://www.wikidata.org/entity/Q37734560

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@en

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@nl

type

label

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@en

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@nl

prefLabel

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@en

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@nl

P1433

Q37734560-3F334262-E0C0-47C5-B34F-651AE222092E

P1476

Q37734560-BAE1B846-4EE4-4A34-BF2E-A611832EBD5C

P2093

Q37734560-9AE7E980-127C-4D0D-8DAD-EA35C89242AA

Q37734560-A3C860A0-355B-42AD-8D58-31700A982716

P2860

Q37734560-069259B9-D2DF-4F92-AFEB-01C099934848

Q37734560-0F9FC3DB-8AFA-4C81-8793-616BB8A62416

Q37734560-24E79F28-190E-49F9-AFFE-D134A8D0E3FE

Q37734560-25AA3AA7-87D7-4361-B9C0-A971F1CFDBA1

Q37734560-26822F6B-721E-477C-9BD0-AC374BA8C00F

Q37734560-28C47FC2-0305-4E0D-A8D1-ED48F2D1F8DA

Q37734560-30F2FD9E-B88C-407E-9C2A-41D819B260FB

Q37734560-3C2AE5DF-132D-4294-9D1D-FFF30B86317B

Q37734560-3DF0F659-4EB2-47A0-9F15-8DF1FDA2C760

Q37734560-45F98A61-4316-46E3-98A0-498AD261E42F

P304

Q37734560-12726D92-460E-4A9F-84AC-553D72D4F80F

P31

Q37734560-87218B70-B117-4F86-9FBF-371ABF1C3EB9

P356

Q37734560-EF549223-8C6C-4597-A2C1-086ADFB51CEF

P433

Q37734560-8F189611-6275-4942-8328-599C1A5AE958

P478

Q37734560-4E40E810-2CBE-4427-BDEC-42172DB4CBA9

P577

Q37734560-FE536132-64E0-4686-A950-77D76632A890

P5875

Q37734560-29B20066-192E-4135-A7C0-BD7247FDA99E

P698

Q37734560-70C2DDA8-1F4D-4248-93B0-0EB40FA05582

P356

J.1755-5922.2010.00153.X

P1433

Cardiovascular Therapeutics

P1476

Therapeutic angiogenesis for the management of refractory angina: current concepts.

@en

P2093

Gary Schaer

http://www.w3.org/2001/XMLSchema#string

Steve Attanasio

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of putative progenitor endothelial cells for angiogenesis

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.

Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization.

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial.

Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularization.

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials.

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels.

An examination of potential mechanisms underlying transmyocardial laser revascularization induced increases in myocardial blood flow.

Clinical experience with the holmium:YAG laser for transmyocardial laser revascularization and myocardial denervation as a mechanism.

P304

e1-e11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2010.00153.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43226198

http://www.w3.org/2001/XMLSchema#string

P698

20406245

http://www.w3.org/2001/XMLSchema#string